Echocardiographic Predictors of an Adverse Response to a Nifedipine Trial in Primary Pulmonary Hypertension
- 1 November 1999
- Vol. 116 (5) , 1218-1223
- https://doi.org/10.1378/chest.116.5.1218
Abstract
No abstract availableKeywords
This publication has 23 references indexed in Scilit:
- Inhaled nitric oxide in primary pulmonary hypertensionJournal of the American College of Cardiology, 1998
- Primary Pulmonary HypertensionNew England Journal of Medicine, 1997
- A Comparison of Continuous Intravenous Epoprostenol (Prostacyclin) with Conventional Therapy for Primary Pulmonary HypertensionNew England Journal of Medicine, 1996
- Single Lung Transplantation for Pulmonary HypertensionCirculation, 1995
- Inhaled nitric oxide as a screening vasodilator agent in primary pulmonary hypertension. A dose-response study and comparison with prostacyclin.American Journal of Respiratory and Critical Care Medicine, 1995
- Effects of adenosine in combination with calcium channel blockers in patients with primary pulmonary hypertensionJournal of the American College of Cardiology, 1993
- The Effect of High Doses of Calcium-Channel Blockers on Survival in Primary Pulmonary HypertensionNew England Journal of Medicine, 1992
- Comparison of the effects of adenosine and nifedipine in pulmonary hypertensionJournal of the American College of Cardiology, 1992
- The Acute Administration of Vasodilators in Primary Pulmonary Hypertension: Experience from the National Institutes of Health Registry on Primary Pulmonary HypertensionAmerican Review of Respiratory Disease, 1989
- High-dose calcium channel-blocking therapy for primary pulmonary hypertension: evidence for long-term reduction in pulmonary arterial pressure and regression of right ventricular hypertrophy.Circulation, 1987